CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Novo Nordisk A/S - share repurchase programme

Neutral
AI Analysis

Summary

Novo Nordisk announced continuation of its share repurchase programme initiated on May 6, 2026, with a total value of up to DKK 15 billion over a 12-month period beginning February 4, 2026.

Importance:2/10
Sentiment:
0.00
share repurchasecapital allocationshareholder return
Related Companies

Read the original article

Published by GlobeNewswire Pharma on August 10, 2026 1:35 PM

Read Original